Ascendis Health (JSE:ASC) Stock Based Compensation: R0 Mil (TTM As of Jun. 2023)


JSE:ASC Ascendis Health Ltd JSE:ASC
11 GF Score
Price R0.92
View Full Analysis

What is Ascendis Health Stock Based Compensation?

Ascendis Health JSE:ASC 11 Stock Based Compensation is R0 Mil as of Jun. 2023. GuruFocus rates JSE:ASC with a GF Score™ of 11/100.

Ascendis Health's Stock Based Compensation for the six months ended in Jun. 2023 was R0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was R0 Mil.

Ascendis Health Stock Based Compensation Related Terms

Ascendis Health Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Ascendis Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Health Stock Based Compensation Chart

Ascendis Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ascendis Health Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
JSE:ASC
11GF Score
Ascendis Health Ltd JSE:ASC
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was R0 Mil.

What does a Stock Based Compensation of R0 Mil mean?
Ascendis Health (JSE:ASC) has a Stock Based Compensation of R0 Mil as of Jun. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Ascendis Health and its competitors.
Is Ascendis Health's Stock Based Compensation too high?
Ascendis Health's current Stock Based Compensation is R0 Mil. Overall, Ascendis Health has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Health's Stock Based Compensation compare to PHBI and GCAN?
Ascendis Health's Stock Based Compensation of R0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Distribution company?
A good Stock Based Compensation depends on the Medical Distribution industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Ascendis Health and its competitors. Ascendis Health's current Stock Based Compensation is R0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Health stock overvalued right now?
Ascendis Health (JSE:ASC) has a current Stock Based Compensation of R0 Mil. The current Stock Based Compensation is R0 Mil. Ascendis Health's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Ascendis Health (JSE:ASC), the current Stock Based Compensation is R0 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Health Business Description

Address 1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090
Ascendis Health Ltd is a health and wellness investment holding Company that holds investments in a number of companies that market and distribute a portfolio of brands, products, and medical devices. The company operates in two segments: i) Consumer Health (wellness, health supplements, speciality ingredients and compounded medicines) and ii) Medical Devices (distributor of medical devices, in vitro diagnostic products and orthopaedic equipment). The company generates the majority of its revenue from the Medical Devices segment.
11GF Score

Get the complete analysis for JSE:ASC

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.92
Price